Qube Research & Technologies LTD Icad Inc Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Icad Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 2 shares of ICAD stock, worth $3. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 2
-0.0%
Holding current value
$3
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ICAD
# of Institutions
57Shares Held
5.92MCall Options Held
1.5KPut Options Held
20.4K-
Vanguard Group Inc Valley Forge, PA1.13MShares$1.78 Million0.0% of portfolio
-
First Eagle Investment Management, LLC702KShares$1.1 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA653KShares$1.03 Million0.08% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny486KShares$763,3180.0% of portfolio
-
Black Rock Inc. New York, NY350KShares$549,4570.0% of portfolio
About ICAD INC
- Ticker ICAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,333,900
- Market Cap $39.8M
- Description
- iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...